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The study was conducted to determine the correlations
between serum concentration of selected macro- and
microelements, namely: magnesium (Mg), copper (Cu),
zinc (Zn), arsenic (As), calcium (Ca), cadmium (Cd)
chromium (Cr) and selenium (Se) with increased or
decreased predisposition to breast and ovarian cancer.
The subjects selected for the trial were Polish women,
positive for at least one of three founder mutations in
BRCA1 gene dominating in Poland (5382insC, C61G,
4153delA). Persons with detected tumor were consid-
ered as cases and the others were considered as con-
trols. One case and two controls were paired regarding
many criteria (e.g. age, family cancer history, cigarettes
smoking) to achieve the maximum of similarity between
them.
All the elements were quantitatively measured simul-
taneously in diluted serum samples by inductively
coupled plasma mass spectrometry (ICP-MS) using
mass spectrometer (Elan DRC-e, PerkinElmer) in stan-
dard mode (Mg, Cu, Zn) and in DRC mode (As, Ca, Cd,
Cr) with methane as a reaction gas, for removing polya-
tomic interferences in measurement.
Table 1 Arsenic and zinc concentration in each quartiles
As (µg/l) Cases (n=99) Controls (n=198) OR p-value
1,14 – 3,64[ 20(20,2%) 53(26,8%) 1,000 -
[3,64 – 4,51[ 29(29,3%) 45(22,7%) 1,708 0.0098
[4,51 – 5,70[ 24(24,2%) 51(25,7%) 1,247 0.00719
[5,70 – 57,66 26(26,3%) 49(24,7%) 1,406 0.04843
Zn (µg/l) Cases (n=99) Controls (n=198) OR p-value
218,89 – 692,48[ 31(31,3%) 43(21,7%) 1,000 -
[692,48 – 756,01[ 18(18,2%) 56(28,3%) 0,446 0.02709
[756,01 – 838,00[ 24(24,2%) 50(25,3%) 0,666 0.07447
[838,00 – 1911,15 26(26,3%) 49(24,7%) 0,736 0.13030
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Table 2 Ratios between analyzed elements and selenium
As/Se Cases (n=99) Controls (n=198) OR p-value
0.016 - 0.044[ 21(21,2%) 53(26,8%) 1,000 -
[0.044 - 0.058[ 21(21,2%) 53(26,8%) 1,000 0.163776
[0.058 - 0.072 31(31,3%) 43(21,7%) 1,819 0.000587
[0.072 - 0.14 26(26,3%) 49(24,7%) 1,339 0.005561
Mg/Se Cases (n=99) Controls (n=198) OR p-value
17.5 - 226[ 31(31,3%) 43(21,7%) 1,000 -
[226 - 257[ 16(16,2%) 58(29,3%) 0,383 0.006663
[257 - 292[ 30(30,3%) 44(22,2%) 0,946 0.815701
[292 - 456 22(22,2%) 53(26,8%) 0,576 0.003590
Zn/Se Cases (n=99) Controls (n=198) OR p-value
0.6 - 8.6[ 29(29,3%) 45(22,7%) 1,000 -
[8.6 - 9.8[ 21(21,2%) 53(26,8%) 0,615 0.217975
[9.8 - 11.1[ 22(22,2%) 52(26,3%) 0,656 0.042510
[11.1 - 29.1 27(27,3%) 48(24,2%) 0,873 0.082148
Ca/Se Cases (n=99) Controls (n=198) OR p-value
65.25 - 810[ 25(25,3%) 49(24,7%) 1,000 -
[810 - 913[ 21(21,2%) 53(26,8%) 0,777 0.976515
[913 - 996[ 24(24,2%) 50(25,3%) 0,941 0.112279
[996 - 1638 29(29,3%) 46(23,2%) 1,236 0.017070
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arsenic and zinc. In case of arsenic, individuals classified
in the second and fourth quartile had a significantly
higher risk of breast or ovarian cancer than those in the
first quartile. In case of zinc a significantly lower risk of
breast or ovarian cancer was observed among indivi-
duals classified in the second quartile. The data are
shown in Table 1.
Apart from the influence of single elements some
interactions from combinations of arsenic, magnesium,
cadmium, zinc and calcium with selenium were also
analyzed. The combinations with statistically significant
differences between quartiles in the disease risk are
shown in Table 2.
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